Literature DB >> 1431824

The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.

M Bell1, R Milstein, J Beam-Goulet, P Lysaker, D Cicchetti.   

Abstract

In a psychiatric rehabilitation study, 154 concurrent ratings were performed using the 30-item Positive and Negative Syndrome Scale (PANSS) and the 18-item Brief Psychiatric Rating Scale (BPRS). Although both instruments had excellent interrater reliability, the PANSS was consistently better: on the 18 symptom items the two instruments share, the PANSS had higher intraclass r's on 14; for the syndromes, the PANSS was higher than the BPRS on positive, negative, and total. Weighted Kappas comparing shared items revealed that most were not interchangeable, with only three coefficients in the excellent range. However, syndrome scale scores were very highly correlated and resulted in similar classification for negative schizophrenia. Ten of the 12 items of the PANSS not included in the BPRS had low zero-order correlations with BPRS items, which suggests that they measure symptoms distinct from those measured by the BPRS and should add to clinical predictive power. This proved true in our study of rehabilitation of patients with schizophrenia. PANSS symptom ratings explained up to 55% of the variance on seven measures of work performance, whereas the BPRS had lower predictive power on six of the seven measures. We concluded that the PANSS may be superior to the BPRS in clinical research on schizophrenia and that most BPRS items are not interchangeable with identically named PANSS items.

Entities:  

Mesh:

Year:  1992        PMID: 1431824     DOI: 10.1097/00005053-199211000-00007

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  50 in total

Review 1.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

2.  The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study.

Authors:  Paul E Bebbington; Matthias Angermeyer; Jean-Michel Azorin; Traolach Brugha; Reinhold Kilian; Sonia Johnson; Mondher Toumi; Asa Kornfeld
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-09       Impact factor: 4.328

3.  Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Schizophr Bull       Date:  2013-07-24       Impact factor: 9.306

4.  Resting-State Functional Network Organization Is Stable Across Adolescent Development for Typical and Psychosis Spectrum Youth.

Authors:  Maria Jalbrzikowski; Fuchen Liu; William Foran; Kathryn Roeder; Bernie Devlin; Beatriz Luna
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

Review 5.  Meta-analysis of Dropout Rates in Placebo-Controlled Randomized Clinical Trials of Atypical Antipsychotics Assessed by PANSS.

Authors:  Akiko Matsusaki; Masayuki Kaneko; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2019-10       Impact factor: 2.859

Review 6.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

7.  Differentiating between clinical and behavioral phenotypes in first-episode psychosis during maintenance of visuospatial working memory.

Authors:  Maria Jalbrzikowski; Vishnu P Murty; Patricia L Stan; Jusmita Saifullan; Daniel Simmonds; William Foran; Beatriz Luna
Journal:  Schizophr Res       Date:  2017-11-11       Impact factor: 4.939

8.  Forty-two-years later: the outcome of childhood-onset schizophrenia.

Authors:  H Remschmidt; M Martin; C Fleischhaker; F M Theisen; K Hennighausen; C Gutenbrunner; E Schulz
Journal:  J Neural Transm (Vienna)       Date:  2006-08-10       Impact factor: 3.575

9.  WHEN PARENTS WITH SEVERE MENTAL ILLNESS LOSE CONTACT WITH THEIR CHILDREN: ARE PSYCHIATRIC SYMPTOMS OR SUBSTANCE USE TO BLAME?

Authors:  Danson Jones; Rosemarie Lillianne Macias; Paul B Gold; Paul Barreira; William Fisher
Journal:  J Loss Trauma       Date:  2008-07-01

10.  Demographic and clinical correlates of substance abuse comorbidity in schizophrenia.

Authors:  Tapas K Aich; Vinod K Sinha; Christoday R J Khess; Shailja Singh
Journal:  Indian J Psychiatry       Date:  2004-04       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.